The present study establishes that Na+ regulates a PLC/IP3‐dependent Ca2+ release in metastatic breast cancer cells; however, the molecular identity of the Na+ “sensor” that initiates this event remains unknown. The gene discussed is HSPG2; the disease is breast cancer.